Cargando…

Expanding adverse outcome pathways towards one health models for nanosafety

The ever-growing production of nano-enabled products has generated the need for dedicated risk assessment strategies that ensure safety for humans and the environment. Transdisciplinary approaches are needed to support the development of new technologies while respecting environmental limits, as als...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saarimäki, Laura Aliisa, del Giudice, Giusy, Greco, Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Toxicology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485555/ https://www.ncbi.nlm.nih.gov/pubmed/37692900 http://dx.doi.org/10.3389/ftox.2023.1176745

Ejemplares similares

Don’t sweat the small stuff: a conversation about nanosafety
por: Fadeel, Bengt, et al.
Publicado: (2023)

Advancing chemical safety assessment through an omics-based characterization of the test system-chemical interaction
por: del Giudice, Giusy, et al.
Publicado: (2023)

Toxicogenomics Data for Chemical Safety Assessment and Development of New Approach Methodologies: An Adverse Outcome Pathway‐Based Approach
por: Saarimäki, Laura Aliisa, et al.
Publicado: (2022)

Reactive Oxygen Species in the Adverse Outcome Pathway Framework: Toward Creation of Harmonized Consensus Key Events
por: Tanabe, Shihori, et al.
Publicado: (2022)

A curated gene and biological system annotation of adverse outcome pathways related to human health
por: Saarimäki, Laura Aliisa, et al.
Publicado: (2023)

Caenorhabditis elegans Neurotoxicity Testing: Novel Applications in the Adverse Outcome Pathway Framework
por: Sammi, Shreesh Raj, et al.
Publicado: (2022)

Adverse Outcome Pathway Development for Assessment of Lung Carcinogenicity by Nanoparticles
por: Nymark, Penny, et al.
Publicado: (2021)

TinderMIX: Time-dose integrated modelling of toxicogenomics data
por: Serra, Angela, et al.
Publicado: (2020)

Integration of Adverse Outcome Pathways, Causal Networks and ‘Omics to Support Chemical Hazard Assessment
por: Perkins, Edward J., et al.
Publicado: (2022)

From Causal Networks to Adverse Outcome Pathways: A Developmental Neurotoxicity Case Study
por: Ramšak, Živa, et al.
Publicado: (2022)

Evidenced-Based Approaches to Support the Development of Endocrine-Mediated Adverse Outcome Pathways: Challenges and Opportunities
por: Audouze, Karine, et al.
Publicado: (2021)

Daphnia as a model organism to probe biological responses to nanomaterials—from individual to population effects via adverse outcome pathways
por: Reilly, Katie, et al.
Publicado: (2023)

An Adverse Outcome Pathway for Decreased Lung Function Focusing on Mechanisms of Impaired Mucociliary Clearance Following Inhalation Exposure
por: Luettich, Karsta, et al.
Publicado: (2021)

Development of a data-driven approach to Adverse Outcome Pathway network generation: a case study on the EATS-modalities
por: Wiklund, Linus, et al.
Publicado: (2023)

Mapping Adverse Outcome Pathways for Kidney Injury as a Basis for the Development of Mechanism-Based Animal-Sparing Approaches to Assessment of Nephrotoxicity
por: Mally, Angela, et al.
Publicado: (2022)

Application of the Adverse Outcome Pathway Concept to In Vitro Nephrotoxicity Assessment: Kidney Injury due to Receptor-Mediated Endocytosis and Lysosomal Overload as a Case Study
por: Jarzina, Sebastian, et al.
Publicado: (2022)

A Case Study on Integrating a New Key Event Into an Existing Adverse Outcome Pathway on Oxidative DNA Damage: Challenges and Approaches in a Data-Rich Area
por: Huliganga, Elizabeth, et al.
Publicado: (2022)

Mapping DEHP to the adverse outcome pathway network for human female reproductive toxicity
por: Pogrmic-Majkic, Kristina, et al.
Publicado: (2022)

FunMappOne: a tool to hierarchically organize and visually navigate functional gene annotations in multiple experiments
por: Scala, Giovanni, et al.
Publicado: (2019)

Characterization of ENM Dynamic Dose-Dependent MOA in Lung with Respect to Immune Cells Infiltration
por: Serra, Angela, et al.
Publicado: (2022)

ESPERANTO: a GLP-field sEmi-SuPERvised toxicogenomics metadAta curatioN TOol
por: Di Lieto, Emanuele, et al.
Publicado: (2023)

Characterization of Chemical Suicides in the United States and Its Adverse Impact on Responders and Bystanders
por: Anderson, Ayana R.
Publicado: (2016)

Reports of Doses Administered and Adverse Reactions to Snake Antivenom Used in Uruguay in 2018
por: Negrin, Alba, et al.
Publicado: (2021)

Adverse effects of maternal exposure to bisphenol F on the anxiety- and depression-like behavior of offspring
por: OHTANI, Naoko, et al.
Publicado: (2016)

Harnessing the Biology of Canine Intestinal Organoids to Heighten Understanding of Inflammatory Bowel Disease Pathogenesis and Accelerate Drug Discovery: A One Health Approach
por: Kopper, Jamie J., et al.
Publicado: (2021)

Do macrophages play a role in the adverse effects of endocrine disrupting chemicals (EDCs) on testicular functions?
por: Cui, Haoyi, et al.
Publicado: (2023)

Transgenerational effects of developmental neurotoxicity induced by exposure to a no-observed-adverse-effect level (NOAEL) of neonicotinoid pesticide clothianidin
por: SHODA, Asuka, et al.
Publicado: (2023)

Investigating the in vitro steatotic mixture effects of similarly and dissimilarly acting test compounds using an adverse outcome pathway-based approach
por: Alarcan, Jimmy, et al.
Publicado: (2021)

Effects of in utero and lactational exposure to the no-observed-adverse-effect level (NOAEL) dose of the neonicotinoid clothianidin on the reproductive organs of female mice
por: KITAUCHI, Sayaka, et al.
Publicado: (2021)

Elucidation of the neurological effects of clothianidin exposure at the no-observed-adverse-effect level (NOAEL) using two-photon microscopy in vivo imaging
por: NISHI, Misaki, et al.
Publicado: (2022)

Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development
por: YABUSAKI, Risa, et al.
Publicado: (2015)

INVESTIGATING ALTERNATIVES TO THE FISH EARLY-LIFE STAGE TEST: A STRATEGY FOR DISCOVERING AND ANNOTATING ADVERSE OUTCOME PATHWAYS FOR EARLY FISH DEVELOPMENT
por: Villeneuve, Daniel, et al.
Publicado: (2014)

NanoSolveIT Project: Driving nanoinformatics research to develop innovative and integrated tools for in silico nanosafety assessment
por: Afantitis, Antreas, et al.
Publicado: (2020)

Fetal and lactational exposure to the no-observed-adverse-effect level (NOAEL) dose of the neonicotinoid pesticide clothianidin inhibits neurogenesis and induces different behavioral abnormalities at the developmental stages in male mice
por: MAEDA, Mizuki, et al.
Publicado: (2021)

Defining the Biologically Plausible Taxonomic Domain of Applicability of an Adverse Outcome Pathway: A Case Study Linking Nicotinic Acetylcholine Receptor Activation to Colony Death
por: Jensen, Marissa A., et al.
Publicado: (2022)

Evaluation of the Dermal Toxicity of InZnP Quantum Dots Before and After Accelerated Weathering: Toward a Safer-By-Design Strategy
por: Dussert, Fanny, et al.
Publicado: (2021)

From vision toward best practices: Evaluating in vitro transcriptomic points of departure for application in risk assessment using a uniform workflow
por: Reardon, Anthony J. F., et al.
Publicado: (2023)

Identification of a Gene Signature Predicting (Nano)Particle-Induced Adverse Lung Outcome in Rats
por: Valentino, Sarah Amandine, et al.
Publicado: (2023)

Potential of NRF2 Pathway in Preventing Developmental and Reproductive Toxicity of Fine Particles
por: Li, Ying-Ji, et al.
Publicado: (2021)

Using Live Imaging and FUCCI Embryonic Stem Cells to Rank DevTox Risks: Adverse Growth Effects of PFOA Compared With DEP Are 26 Times Faster, 1,000 Times More Sensitive, and 13 Times Greater in Magnitude
por: Abdulhasan, Mohammed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rc7r002m1aervdlb2mgk0hvbao